mbqpharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title MBQ Pharma – Metastasis-Blocking Cancer
Description Precision Targeting GTPases in Cancer, Autoimmunity and Toggle Navigation Home Science Team News Contact Search for: MBQ Pharma Flamingo Design 2023-05-01T15:25:25-04:00 Precision Targeting GTPases in Cancer, A
Keywords N/A
Server Information
WebSite mbqpharma faviconmbqpharma.com
Host IP 162.241.252.116
Location United States
Related Websites
Site Rank
More to Explore
mbqpharma.com Valuation
US$282,025
Last updated: 2023-05-19 20:10:29

mbqpharma.com has Semrush global rank of 37,529,672. mbqpharma.com has an estimated worth of US$ 282,025, based on its estimated Ads revenue. mbqpharma.com receives approximately 32,542 unique visitors each day. Its web server is located in United States, with IP address 162.241.252.116. According to SiteAdvisor, mbqpharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$282,025
Daily Ads Revenue US$261
Monthly Ads Revenue US$7,810
Yearly Ads Revenue US$93,720
Daily Unique Visitors 2,170
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
mbqpharma.com. A 14397 IP: 162.241.252.116
mbqpharma.com. NS 21600 NS Record: ns2.bluehost.com.
mbqpharma.com. NS 21600 NS Record: ns1.bluehost.com.
mbqpharma.com. MX 14400 MX Record: 0 mail.mbqpharma.com.
mbqpharma.com. MX 14400 MX Record: 1 aspmx.l.google.com.
mbqpharma.com. MX 14400 MX Record: 10 alt4.aspmx.l.google.com.
mbqpharma.com. MX 14400 MX Record: 5 alt2.aspmx.l.google.com.
mbqpharma.com. TXT 14400 TXT Record: v=spf1 a mx include:websitewelcome.com ~all
HtmlToTextCheckTime:2023-05-19 20:10:29
Toggle Navigation Home Science Team News Contact Search for: MBQ Pharma Flamingo Design 2023-05-01T15:25:25-04:00 Precision Targeting GTPases in Cancer, Autoimmunity and Fibrosis Precision Targeting GTPases in Cancer, Autoimmunity and Fibrosis MBQ-167 Our lead compound, MBQ-167, is a first-in-class therapeutic which simultaneously inhibits both Rac and CDC42, removing pre-existing metastases. MBQ-167 is currently in its Phase-1 study. Prevention of Metastatic Growth and Removal of Pre-Existing Metastases Cancer mortality is closely linked to metastasis Rac and Cdc42 are key genes in the development of metastasis MBQ-167 is a first-in-class dual inhibitor of activation for Rac & Cdc42 MBQ-167 + Paclitaxel remove pre-existing metastases MBQ Pharma leads in the science and development of Rac & Cdc42 inhibitors We are the first Why is the simultaneous inhibition of Rac and CDC42 so important? The simultaneous silencing of Rac and CDC42 genes can also be shown to remove pre-existing
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 17 Nov 2022 08:47:24 GMT
Server: Apache
X-Pingback: http://mbqpharma.com/xmlrpc.php
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: https://mbqpharma.com/
host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ==
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
x-pingback: https://mbqpharma.com/xmlrpc.php
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ==
content-type: text/html; charset=UTF-8
date: Thu, 17 Nov 2022 08:47:27 GMT
server: Apache
mbqpharma.com Whois Information
Domain Name: MBQPHARMA.COM
Registry Domain ID: 2254599358_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.fastdomain.com
Registrar URL: http://www.fastdomain.com
Updated Date: 2022-04-05T14:16:45Z
Creation Date: 2018-04-20T04:16:17Z
Registry Expiry Date: 2023-04-20T04:16:17Z
Registrar: FastDomain Inc.
Registrar IANA ID: 1154
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.BLUEHOST.COM
Name Server: NS2.BLUEHOST.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-11-17T08:46:38Z <<<

Copyright © 2022 WebZZ.US 0.0250